Food Poisoning and Toxic Exposure Case Study: GI Recovery and Pharmacy Lien Documentation

James Wong — Founder & CEO, LienScripts | March 4, 2026 | 8 min read

A severe food poisoning incident at a restaurant caused prolonged gastrointestinal damage requiring 9 months of medication management. This case study examines how a pharmacy lien covered the treatment while the negligence claim against the restaurant proceeded.

Severe food poisoning cases can produce prolonged gastrointestinal damage that requires months of pharmaceutical management. While many food poisoning incidents resolve within days, cases involving particularly virulent pathogens or compromised patients can result in chronic conditions with significant medication needs.

Note: This is a fictionalized case study based on composite facts. Names and identifying details are not real. The clinical details represent typical medication patterns for this injury type.

• Severe food poisoning from bacterial contamination can cause chronic post-infectious irritable bowel syndrome (PI-IBS), reactive arthritis, and other long-term complications
• Restaurant negligence in food safety creates liability for both acute illness and chronic sequelae
• A 9-month pharmacy lien documented the full gastrointestinal recovery trajectory from acute infection through chronic management
• LienScripts' MERIT (Medication Evaluation & Rationale for Injury Treatment) report connected the medication regimen to the specific foodborne pathogen identified in testing
• The defense argued that GI symptoms were pre-existing; the pharmacy record showed no prior GI medications

Case Background

Patient: Lisa M. (name changed), 52-year-old female, real estate agent

Incident: Lisa dined at a restaurant that was subsequently cited by the local health department for multiple food safety violations following a cluster of foodborne illness reports. Lisa consumed undercooked chicken that was later linked to Salmonella contamination through stool culture testing.

Injuries: Severe Salmonella gastroenteritis requiring hospitalization, post-infectious reactive arthritis (an autoimmune response triggered by the Salmonella infection), and post-infectious irritable bowel syndrome (PI-IBS) persisting months after the acute infection resolved.

Initial Treatment: Lisa presented to the emergency department three days after the meal with severe diarrhea, abdominal cramping, fever, and dehydration. She was admitted for IV fluid resuscitation and monitored for 48 hours. Stool culture confirmed Salmonella enteritidis. She was discharged with oral rehydration and follow-up with gastroenterology.

Insurance Situation: Lisa had an individual marketplace plan with limited gastroenterology coverage. Several GI-specific medications required prior authorization or were not on the plan's formulary.

Attorney: Hannah R. (name changed), a plaintiff attorney with food safety litigation experience.

The Pharmacy Lien: 9 Months of Coverage

Hannah enrolled Lisa in the LienScripts pharmacy lien program after the acute hospitalization, when it became clear that Lisa's recovery would extend well beyond the initial infection. The prior authorization barriers through her insurance plan were delaying access to GI medications her gastroenterologist had prescribed.

Medication Timeline

Acute Infection Phase: Months 1-2

Azithromycin 500mg daily for 7 days — antibiotic therapy for the Salmonella infection. While many Salmonella cases are self-limiting, Lisa's severe presentation with hospitalization warranted antibiotic treatment.

Ondansetron 4mg every 8 hours as needed for persistent nausea.

Loperamide 2mg as needed for diarrhea management after the acute infectious phase, prescribed with careful monitoring to avoid complications.

Oral rehydration solution packets — while not a traditional prescription, the pharmacy lien covered the medical-grade oral rehydration prescribed by the gastroenterologist.

Post-Infectious Complications: Months 3-6

By month 3, the acute Salmonella infection had resolved but Lisa developed two significant complications:

Post-infectious reactive arthritis. She developed joint pain and swelling in the knees and ankles — a recognized autoimmune complication of Salmonella infection. Treatment included:

• Naproxen 500mg twice daily as first-line anti-inflammatory therapy for the reactive arthritis
• Sulfasalazine 500mg twice daily, titrated to 1000mg twice daily — a disease-modifying agent for reactive arthritis that did not respond adequately to NSAIDs alone

Post-infectious IBS (PI-IBS). Lisa developed chronic abdominal pain, bloating, and alternating diarrhea and constipation — a well-documented sequel of severe bacterial gastroenteritis. Treatment included:

• Dicyclomine 20mg four times daily for abdominal cramping and spasm
• Rifaximin 550mg three times daily for 14 days — an antibiotic used for IBS-related symptoms, specifically targeting small intestinal bacterial overgrowth (SIBO) that can develop after severe GI infections
• Pantoprazole 40mg daily for the upper GI symptoms and acid management

According to James Wong, PharmD, founder of LienScripts, "Food poisoning cases that produce chronic post-infectious complications are uniquely suited to pharmacy lien documentation. The dated medication record shows the progression from acute infection to chronic condition — a timeline that directly proves causation between the foodborne exposure and the ongoing symptoms."

Chronic Management: Months 7-9

Amitriptyline 10mg at bedtime was added at month 7 for the combination of visceral hypersensitivity (a recognized feature of PI-IBS) and the insomnia and anxiety that the prolonged GI illness had produced.

Probiotics (prescription-strength VSL#3) were prescribed at month 7 to support GI microbiome restoration after the infection and antibiotic treatments.

Sulfasalazine was tapered and discontinued at month 8 as the reactive arthritis improved.

By month 9, Lisa's PI-IBS had stabilized with ongoing dicyclomine and amitriptyline. Her gastroenterologist documented a chronic condition requiring continued management, with the post-infectious etiology clearly attributed to the Salmonella exposure.

How Pharmacy Documentation Supported the Case

The defense argued that Lisa's GI symptoms were pre-existing or unrelated to the restaurant meal. Hannah used the pharmacy record to refute this:

• No pre-incident GI medications existed in Lisa's pharmacy history
• The medication timeline showed a clear progression from acute Salmonella treatment to post-infectious complications — reactive arthritis and PI-IBS — with onset dates correlating to the established post-infectious timeline
• The MERIT report connected every medication to the specific pathogen (Salmonella enteritidis) confirmed by laboratory testing

The health department's inspection report documenting food safety violations provided the negligence evidence; the pharmacy record provided the causation and damages evidence.

Settlement Outcome

The case settled during mediation. The damages presentation included hospitalization costs, the pharmacy lien balance, gastroenterology consultation fees, projected future GI medication costs, lost real estate commissions during the 9-month recovery, and pain and suffering. The pharmacy documentation's demonstration of a clear causal chain from contaminated food to chronic condition was central to the settlement value.

Related Resources

• GI Protection Medications in Personal Injury
• What Is a MERIT Report?
• Demand Package Pharmacy Records